Continuing Medical Education (CME)
The Orear Institute for Post-Graduate Studies is dedicated to delivering high-quality educational experiences for healthcare professionals. As part of this commitment, we have received accreditation with the American Academy of Family Physicians (AAFP) to offer Continuing Medical Education (CME) credits.
Our CME programming is designed to provide cutting-edge, evidence-based education tailored for family practice physicians, internists, physician assistants, and nurse practitioners. By participating, attendees can enhance their knowledge, refine their clinical skills, and stay updated on the latest advancements in medicine.
Accreditation Status: The AAFP has reviewed Orear Institute's 2025 Recent Advances in Medicine Conference Including Evidence-Based Integrative Medicine and deemed it acceptable for up to 14.00 Live AAFP Prescribed credit(s). Term of Approval is from 06/26/2025 to 06/27/2025. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AMA/AAFP Equivalency - AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.
-
Peter Buch, MD
Clinical Professor at the ECHN Branch of the University of New England College of Osteopathic Medicine; Associate Professor at the University of Connecticut School of Medicine, and the Frank H. Netter, MD School of Medicine, Connecticut
Fecal Incontinence, Hemorrhoids, Fissures and the Primary Care Provider
· To delineate the cause of fecal incontinence
· To outline the stepwise treatment for fecal incontinence
· To differentiate the treatments for internal and external hemorrhoids
· To outline a stepwise treatment for anal fissures
Bootcamp for Elevated Liver Function Tests
· To assess ALL patients with confirmed elevated liver function tests
· To recognize frequently encountered gallbladder and common duct dilemmas
· To identify the changing paradigm in hemochromatosis evaluation
· To describe what a primary care provider should know about Hepatitis C
Gregory S. Canty, MD
Sports Medicine, CMH, UMKC & University of Kansas School of Medicine
Concussion 2025 – What’s New and What Can We Do?
· Review recent literature for diagnosing and managing sports-related concussion.
· Share best practices for managing sports-related concussion from recent consensus.
Sports Medicine for Youth Athletes
· Highlight the epidemiology behind youth sports participation and youth sports injuries.
· Discuss some sports-specific conditions unique to the young athlete. Review recent literature for diagnosing and managing sports-related concussion.
Denise Dupras, MD, PhD
Consultant, Division of Community Internal Medicine; Geriatrics and Palliative Care, Department of Internal Medicine; Associate Professor of Medicine; Mayo Clinic, Rochester, Minnesota
New Drugs, Indications and Warning: Primary Care Update 2025
· Become familiar with new medications that primary care clinicians may use in the care of patients
· Use the information to appropriately determine best patient medication management
· Recognize limitations in the evidence supporting the use of new medications
Common Supplements Patients are Using: Is there Evidence to Support their Use?
· Recognize what is required for a supplement to be available for purchase
· Understand the evidence supporting claims about the efficacy of some commonly used supplements
· Learn where to find information about supplements.
Regis Fernandes, MD
Consultant, Medical Director and Chair, Division of Comprehensive and Preventative Cardiology, Department of Cardiovascular Diseases; Assistant Professor of Medicine; Medical Director/Physician Liaison, Mayo Clinic Cardiac Rehabilitation Council, Mayo Clinic, Scottsdale/Phoenix, Arizona
Clinical Utility of Coronary Artery Calcium Score
· Understand the biology of coronary artery calcification and the strength of evidence for using a Coronoary Calcium Score (CAC) for ASCVD risk prediction.
· Review the most current recommendations for Coronary Calcium Score (CAC) regarding indications, interpretation, and integration of the results in the global risk assessment and management of patients.
· Discuss some of the most common questions from consultants and patients regarding the management of CAC results.
Updates in Lipid Management
· Identify Newer FDA approved non-statin therapies, indications, and % LDL reduction.
· Describe treatment options for the truly statin-intolerant.
· Determine to who and when non-statins should be considered based on the percentage of LDL reduction or LDL range desired for the level of risk.
· Choose which ones to consider and in what order.
Edward J. Mayeaux, Jr., MD, DABFP, DABPM-CI, FAAFP
Medical Director, Ambulatory Quality and Family Medicine Associate Program Director, Lexington Medical Center, Lexington, South Carolina; Professor Emeritus of Family Medicine, Louisiana State University Health Sciences Center, Shreveport, Louisiana
Nail Disorders: The Good, the Bad, and the Ugly
At the completion of this activity, the learner will be able to:
· Manage common nail disorders
· Identify and treat common nail disorders
· Relate nail disorder to systemic disease, when applicable.
Infestations: The things that bug us!
At the completion of this activity, the learner will be able to:
· Distinguish infestations of scabies, head/body lice, and bedbugs from other insect bites and skin disorders.
· Develop treatment plans using the most recent evidence-based recommendations.
Michael Silber, MB, ChB
Consultant neurologist at the Mayo Clinic Center for Sleep Medicine, Rochester, MN; Professor of Neurology and Elliott and Marlys Badzin Neuro-Degenerative Sleep Disorder Professor, Mayo Clinic College of Medicine and Science
The Sleepless Patient: Insomnia Update
Identify the multiple factors that can contribute to chronic insomnia
Understand the principles of cognitive behavioral therapy for insomnia
Select an appropriate medication for treating chronic insomnia, balancing individual patient need with side-effects and precautions.
Restless Leg Syndrome: Challenges and Current Practice
Select appropriate initial therapy for patients with chronic persistent restless legs syndrome
Understand when and how to initiate iron therapy for restless legs syndrome
Develop competence in using low-dose opioids for refractory restless legs syndrome
Kimberly Swan, MD
Board-certified OB/GYN and Program Director at the Kansas City Women’s Clinic ACGME-accredited resident clinic, HCA Midwest Health Physicians Network, and affiliated with the Overland Park Regional Medical Center, Founder of Swan Gynecology, Overland Park, Kansas
Abnormal Uterine Bleeding & Fibroids
· Define abnormal uterine bledding (AUB) and causes as a first objective
· Identify appropriate workup for AUB
· Describe options for managing fibroids
Polycystic Ovary Syndrome (PCOS)
· Describe signs and symptoms of polycystic ovary syndrome (PCOS)
· Understand the work up and diagnostic criteria of PCOS
· Discuss recognized current management of those with PCOS
Douglas Tietjen, MD
Urologist, KCUC Urology & Oncology, Lee’s Summit Missouri, and Overland Park, Kansas
Prostate Cancer Screening and Treatment
· Review the prevalence, biology, and clinical course of prostate cancer.
· Review the current recommendations for prostate cancer screening.
· Review the current clinical work-up for an elevated PSA.
· Review the current treatment options for prostate cancer.
Evaluation of Hematuria
· Review current recommendations for the work-up of microhematuria.
· Review current recommendations for the work up of gross hematuria.
· Review evaluation of hematuria in the presence of UTI’s.
Speaker Commercial Disclosures
In accordance with continuing medical education standards, we disclose any financial relationships or affiliations with commercial entities related to the content of this program. These disclosures are provided to ensure transparency and uphold the integrity of this educational activity.
Speakers
Disclosure
Peter Buch, MD
Nothing to disclose.
Denise Dupras, MD
ParentMD - Consultant
Regis Fernandes, MD
Open DNA - Intellectual Property
Gregory Canty, MD
Nothing to disclose.
E.J. Mayeaux, Jr., MD
Nothing to disclose.
Mayo Clinic - Employee; UpToDate - Author
Michael H. Silber, MB, ChB
J&J, Abbivie - Stock; Merck - Stock; Bristol Myers - Stock
Kimberly Swan, MD
Nothing to disclose.
Douglas Tietjen, MD